{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:47:04Z","timestamp":1785912424407,"version":"3.56.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Portes Foundation"},{"name":"Institute of Medicine of Chicago"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>Opioid overdose education and naloxone distribution (OEND) for use by laypersons has been shown to be safe and effective, but implementation in the emergency department (ED) setting is challenging. Recent literature has shown a discouragingly low rate of obtainment of naloxone that is prescribed in the ED setting. We conducted a study to evaluate the feasibility of point-of-care (POC) distribution of naloxone in an ED, hypothesizing a rate of obtainment higher than prescription fill rates reported in previous studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>A multidisciplinary team of experts, including pharmacists, physicians, nurses, and case management professionals used an iterative process to develop a protocol for POC OEND in the ED. The protocol includes 5 steps: (1) patient screening, (2) order placement in the electronic health record (EHR), (3) a patient training video, (4) dispensing of naloxone kit, and (5) written discharge instructions. The naloxone kits were assembled, labeled to meet requirements for a prescription, and stored in an automated dispensing cabinet. Two pharmacists, 30 attending physicians, 65 resident physicians, and 108 nurses were trained. In 8 months, 134 orders for take-home naloxone were entered and 117 naloxone kits were dispensed, resulting in an obtainment rate of 87.3%. The indication for take-home naloxone kit was heroin use for 61 patients (92.4%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>POC naloxone distribution is feasible and yielded a rate of obtainment significantly higher than previous studies in which naloxone was prescribed. POC distribution can be replicated at other hospitals with low rates of obtainment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajhp\/zxaa409","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T19:43:44Z","timestamp":1612813424000},"page":"360-366","source":"Crossref","is-referenced-by-count":22,"title":["Point-of-care naloxone distribution in the emergency department: A pilot study"],"prefix":"10.1093","volume":"78","author":[{"given":"P Quincy","family":"Moore","sequence":"first","affiliation":[{"name":"Section of Emergency Medicine, Pritzker School of Medicine, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Cheema","sequence":"additional","affiliation":[{"name":"Section of Emergency Medicine, Pritzker School of Medicine, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Celmins","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Follman","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, University of Chicago , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Soni","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Austin","family":"Szwak","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai T","family":"Pho","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Global Health, Pritzker School of Medicine, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keme","family":"Carter","sequence":"additional","affiliation":[{"name":"Section of Emergency Medicine, Pritzker School of Medicine, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet M","family":"Arora","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, University of Chicago Medicine , Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"issue":"2","key":"2024022413552758900_CIT0001","doi-asserted-by":"crossref","first-page":"e180217","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Netw Open."},{"issue":"6","key":"2024022413552758900_CIT0002","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1007\/s11606-019-05448-y","article-title":"An observational study of retail pharmacy naloxone prescriptions: differences across provider specialties and patient populations","volume":"35","author":"Smart","year":"2020","journal-title":"J Gen Intern Med."},{"issue":"43","key":"2024022413552758900_CIT0003","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999-2008","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"1","key":"2024022413552758900_CIT0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal","volume":"158","author":"Coffin","year":"2013","journal-title":"Ann Intern Med."},{"issue":"1","key":"2024022413552758900_CIT0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13722-016-0068-3","article-title":"Opioid overdose prevention and naloxone rescue kits: what we know and what we don\u2019t know","volume":"12","author":"Kerensky","year":"2017","journal-title":"Addict Sci Clin Pract."},{"issue":"5","key":"2024022413552758900_CIT0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11916-018-0685-5","article-title":"America\u2019s opioid epidemic: a comprehensive review and look into the rising crisis","volume":"22","author":"Ostling","year":"2018","journal-title":"Curr Pain Headache Rep."},{"issue":"166","key":"2024022413552758900_CIT0007","first-page":"1","article-title":"Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011","author":"Chen","year":"2014","journal-title":"NCHS Data Brief."},{"issue":"3","key":"2024022413552758900_CIT0008","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1300\/J069v25n03_11","article-title":"Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths","volume":"25","author":"Maxwell","year":"2006","journal-title":"J Addict Dis."},{"key":"2024022413552758900_CIT0009","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ."},{"issue":"10","key":"2024022413552758900_CIT0010","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3109\/15563650.2014.968657","article-title":"Expanding access to naloxone in the United States","volume":"52","author":"Doyon","year":"2014","journal-title":"Clin Toxicol (Phila)."},{"issue":"1","key":"2024022413552758900_CIT0011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0033354917743500","article-title":"Where next for opioids and the law? Despair, harm reduction, lawsuits, and regulatory reform","volume":"133","author":"Burris","year":"2018","journal-title":"Public Health Rep."},{"issue":"20","key":"2024022413552758900_CIT0012","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.2018.4867","article-title":"Increasing naloxone awareness and use: the role of health care practitioners","volume":"319","author":"Adams","year":"2018","journal-title":"JAMA."},{"key":"2024022413552758900_CIT0013","author":"Office of the Surgeon Generak, US Department of Health and Human Services"},{"issue":"1","key":"2024022413552758900_CIT0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annemergmed.2019.07.014","article-title":"Predictors of overdose death among high-risk emergency department patients with substance-related encounters: a data linkage cohort study","volume":"75","author":"Krawczyk","year":"2020","journal-title":"Ann Emerg Med."},{"issue":"1","key":"2024022413552758900_CIT0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-year mortality of patients after emergency department treatment for nonfatal opioid overdose","volume":"75","author":"Weiner","year":"2020","journal-title":"Ann Emerg Med."},{"issue":"5","key":"2024022413552758900_CIT0016","doi-asserted-by":"crossref","first-page":"e193209","DOI":"10.1001\/jamanetworkopen.2019.3209","article-title":"Naloxone prescriptions among commercially insured individuals at high risk of opioid overdose","volume":"2","author":"Follman","year":"2019","journal-title":"JAMA Netw Open."},{"issue":"1","key":"2024022413552758900_CIT0017","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajem.2018.05.044","article-title":"Naloxone prescriptions from the emergency department: an initiative in evolution","volume":"37","author":"Verdier","year":"2019","journal-title":"Am J Emerg Med."},{"issue":"11","key":"2024022413552758900_CIT0018","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.ajem.2018.03.036","article-title":"Emergency physician resistance to a take-home naloxone program led by community harm reductionists","volume":"36","author":"Barbour","year":"2018","journal-title":"Am J Emerg Med."},{"key":"2024022413552758900_CIT0019","first-page":"S101","volume-title":"Annals of Emergency Medicine","author":"Lebin","year":"2017"},{"issue":"1","key":"2024022413552758900_CIT0020","doi-asserted-by":"crossref","first-page":"001","DOI":"10.17352\/2455-3484.000027","article-title":"Naloxone fill rates after opioid overdose","volume":"5","author":"Ruff","year":"2019","journal-title":"J Addict Med Ther Sci."},{"key":"2024022413552758900_CIT0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.01.003","article-title":"Peer-delivered recovery support services for addictions in the united states: a systematic review","volume":"63","author":"Bassuk","year":"2016","journal-title":"J Subst Abuse Treat."},{"issue":"16","key":"2024022413552758900_CIT0022","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/4\/360\/56751926\/zxaa409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/4\/360\/56751926\/zxaa409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T13:57:44Z","timestamp":1708783064000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/78\/4\/360\/6130653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2,8]]},"published-print":{"date-parts":[[2021,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxaa409","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,15]]},"published":{"date-parts":[[2021,2,8]]}}}